List Title | APhA DrugInfoLine

Infectious Diseases

SORT BY: Most Recent Most Viewed

February 28, 2017

Acid blockers may increase risk of bacterial gastroenteritis

READ

PREVIEW
Use of acid-suppression medications was associated with increased rates of Clostridium difficile- and Campylobacter-positive bacterial gastroenteritis, according to results of a...
February 28, 2017

Two doses of HPV vaccine now recommended for select patients

READ

PREVIEW
The Advisory Committee on Immunization Practices (ACIP) released updated human papillomavirus (HPV) vaccine recommendations that discussed use of a two-dose schedule for the 9-valent vaccine for...
January 31, 2017

Longer course of antibiotics better for acute otitis media in young children

READ

PREVIEW
In children aged 6 to 23 months with acute otitis media, limiting antimicrobial treatment to 5 days rather than the standard 10 days resulted in more clinical failures and more symptoms with no...
January 10, 2017

Newer hepatitis C regimens interact with warfarin

READ

PREVIEW
Newer hepatitis C virus (HCV) drug regimens are associated with decreased warfarin responses, with the combination of ombitasvir–paritaprevir–ritonavir and dasabuvir ([OBV–PTV–r/DSV] Viekira—...
December 20, 2016

The Joint Commission releases new antimicrobial stewardship standard

READ

PREVIEW
In June, the Joint Commission released a new antimicrobial stewardship standard that will become effective on January 1, 2017, and focused on key elements such as education of hospital staff about...

Pages

Medication Monitor

RSS Follow Medication Monitor on Twitter Follow APhA Druginfoline on Twitter

2215 Constitution Avenue NW, Washington, DC 20037 Telephone 202-628-4410 Fax 202-783-2351

© 2013 American Pharmacists Association All Rights Reserved.

About the American
Pharmacists Association

The American Pharmacists Association (APhA) is the organization whose members are recognized in society as essential in all patient care settings for optimal medication use that improves health, wellness and quality of life. Through information, education and advocacy, APhA empowers its members to improve medication use and advance patient care.

About APhA DrugInfoLine

APhA DrugInfoLine (ISSN 2162-3015) is a weekly publication of, and is owned and copyrighted by the American Pharmacists Association, the national professional society of pharmacists. Materials in APhA DrugInfoLine do not neccessarily represent the policy, recommendations, or endorsement of APhA. The publisher, authors, editors, reviewers, and contributors have taken care to ensure that the information contained in APhA DrugInfoLine is accurate and current; however, they shall have no ability to any person or entity with regard to claims, losses, or damage caused or alleged to be caused, directly or indirectly by use of any information contained in the publication. All decisions about drug therapy must be based on independent judgement of the clinician.